Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 16;91(2):e0055922.
doi: 10.1128/iai.00559-22. Epub 2023 Jan 18.

The Klebsiella pneumoniae ter Operon Enhances Stress Tolerance

Affiliations

The Klebsiella pneumoniae ter Operon Enhances Stress Tolerance

Sophia Mason et al. Infect Immun. .

Abstract

Healthcare-acquired infections are a leading cause of disease in patients that are hospitalized or in long-term-care facilities. Klebsiella pneumoniae (Kp) is a leading cause of bacteremia, pneumonia, and urinary tract infections in these settings. Previous studies have established that the ter operon, a genetic locus that confers tellurite oxide (K2TeO3) resistance, is associated with infection in colonized patients. Rather than enhancing fitness during infection, the ter operon increases Kp fitness during gut colonization; however, the biologically relevant function of this operon is unknown. First, using a murine model of urinary tract infection, we demonstrate a novel role for the ter operon protein TerC as a bladder fitness factor. To further characterize TerC, we explored a variety of functions, including resistance to metal-induced stress, resistance to radical oxygen species-induced stress, and growth on specific sugars, all of which were independent of TerC. Then, using well-defined experimental guidelines, we determined that TerC is necessary for tolerance to ofloxacin, polymyxin B, and cetylpyridinium chloride. We used an ordered transposon library constructed in a Kp strain lacking the ter operon to identify the genes that are required to resist K2TeO3-induced and polymyxin B-induced stress, which suggested that K2TeO3-induced stress is experienced at the bacterial cell envelope. Finally, we confirmed that K2TeO3 disrupts the Kp cell envelope, though these effects are independent of ter. Collectively, the results from these studies indicate a novel role for the ter operon as a stress tolerance factor, thereby explaining its role in enhancing fitness in the gut and bladder.

Keywords: Klebsiella; tolerance; transposons; urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
TerC is necessary for complete fitness in the bladder during a urinary tract infection. Mice were transurethrally inoculated with approximately 108 CFU of a 1:1 mix of WT NTUH-K2044 and NTUH-K2044ΔterC. (A) The bacterial burden in the urine and bladder was measured after 48 h, and (B) the log10 competitive index (CI) of the mutant strain, compared to the WT strain, was calculated for each organ (N = 17; mean displayed; ****, P < 0.00005; one-sample t test). From 20 inoculated mice, CFU were recovered from 17 mice. The numbers above each column in panel A indicate the number of mice (of 17) with detectable CFU. Blue circles had no recoverable NTUH-K2044ΔterC. The CI was calculated using the limit of detection CFU value when no CFU were recovered.
FIG 2
FIG 2
TerC is necessary for tolerance to several stresses. The (A) K2TeO3 MIC (i: n = 5 independent experiments; median displayed; **, P < 0.005; ratio paired t test) was calculated for the NTUH-K2044 and NTUH-K2044ΔterC strains using broth microdilution. Kill curves (ii: n = 7 independent experiments; mean displayed ± SEM) were generated for these strains via the addition of a standard K2TeO3 concentration of 1 mM to overnight cultures. The (iii) AUC and (iv) MDK were calculated from these kill curves (n = 7 per group; *, P < 0.05; **, P < 0.005; ratio paired t test; ∞ indicates an incalculable MDK). Finally, the NTUH-K2044 pVector, NTUH-K2044ΔterC pVector, and NTUH-K2044ΔterC pTerZ-F survival was assessed at 4 h (240 min) post 1 mM K2TeO3 exposure (v: n = 6 to 7 independent experiments; median displayed; *, P < 0.05; **, P < 0.005; ***, P < 0.0005; one-way ANOVA followed by Tukey’s multiple-comparison test). These experiments were repeated for ofloxacin (B), polymyxin B (PmB) (C), and cetylpyridinium chloride (CPC) (D). The standard concentrations for the killing assays for ofloxacin, polymyxin B, and cetylpyridinium chloride were 250 μg/mL, 500 μg/mL, and 25 μM, respectively. For subpanels iii, iv, and v, the connecting lines indicate paired biological replicates.
FIG 3
FIG 3
Systematic screen of K2TeO3 resistance. The KPPR1 strain, which lacks the ter operon, as well as the the NTUH-K2044 and NTUH-K2044ΔterC strains were cultured in increasing concentrations of K2TeO3 (A). The area under the curve (AUC) was calculated from these dose-response curves (B) (mean displayed ± SEM; ****, P < 0.0005; one-way ANOVA followed by Tukey’s multiple-comparison test). (C) 3,733 individual Tn insertion mutants were cultured in the presence of 1 μM K2TeO3 and were measured at OD600. The blue line is the mean OD600, and the red lines are ± 2 SD from the mean. Each symbol is an individual mutant, ordered by its gene number (VK055_#). (D) Exact K2TeO3 IC50 values of validated Tn insertion mutants (n = 3 to 5 independent experiments). (E) KEGG BRITE functional hierarchies were assigned for the validated Tn insertion mutants. The highest order hierarchies are shown in the horizontal stacked bar chart, and the second-highest order hierarchies are shown in the unstacked bar chart. (F) The validated Tn insertion mutants were cultured in the presence of 0.5 μg/mL PmB (n = 3 independent experiments).
FIG 4
FIG 4
EtBr accumulates in K2TeO3 and polymyxin B treated Kp. Stationary-phase NTUH-K2044 pVector, NTUH-K2044ΔterC pVector, and NTUH-K2044ΔterC pTerZ-F were exposed to 1 mM K2TeO3 or 500 μg/mL PmB. EtBr accumulation (fluorescence) was measured at the baseline and at 1 h postexposure (n = 6 independent experiments; mean displayed; *, P < 0.05; **, P < 0.005; ***, P < 0.0005; one-way ANOVA followed by Tukey’s multiple-comparison test).

Similar articles

Cited by

References

    1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Multistate point-prevalence survey of health care–associated infections. 2014. N Engl J Med 370:1198–1208. doi:10.1056/NEJMoa1306801. - DOI - PMC - PubMed
    1. Antimicrobial Resistance C. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655. doi:10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed
    1. Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj SS, Gao H, Munita JM, Ordoñez K, Weston G, Satlin MJ, Valderrama-Beltrán SL, Marimuthu K, Stryjewski ME, Komarow L, Luterbach C, Marshall SH, Rudin SD, Manca C, Paterson DL, Reyes J, Villegas MV, Evans S, Hill C, Arias R, Baum K, Fries BC, Doi Y, Patel R, Kreiswirth BN, Bonomo RA, Chambers HF, Fowler VG, Arias CA, van Duin D, Multi-Drug Resistant Organism Network I . 2022. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis 22:401–412. doi:10.1016/S1473-3099(21)00399-6. - DOI - PMC - PubMed
    1. Xu L, Sun X, Ma X. 2017. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 16:18. doi:10.1186/s12941-017-0191-3. - DOI - PMC - PubMed
    1. Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. 2020. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents 55:105833. doi:10.1016/j.ijantimicag.2019.10.014. - DOI - PubMed

Publication types